Computed tomography features of Stenotrophomonas maltophilia pneumonia in patients with neutropenic fever: report of two cases
© Tsang et al.; licensee BioMed Central Ltd. 2013
Received: 12 August 2012
Accepted: 22 January 2013
Published: 18 February 2013
Stenotrophomonas maltophilia (S. maltophilia) is a rare yet important global emerging nosocomial pathogen with multi-drug resistance. To the best of our knowledge, there is only one case report describing the computer tomography (CT) features of S. maltophilia pneumonia. In this article we will compare the features in the published case to those found in our patients. The importance of thoracic CT in febrile neutropenic patients will also be discussed.
KeywordsStenotrophomonas maltophilia Stenotrophomonas Xanthomonas Pneumonia Neutropenia Neutropenic fever Fever of unknown origin
Infection is the major cause of neutropenic fever in patients receiving chemotherapy, with the pulmonary system being most commonly involved. With the advantage of being readily accessible, chest radiography (CXR) is most often the first imaging test used. However, it may not be sufficiently sensitive or specific in diagnosing pulmonary infection. Compared to CXR, thoracic computed tomography (CT) much more sensitive in the detection of pulmonary infection in immunocompromised patients[2–8]. Therefore some authors advocate the use of thoracic CT in neutropenic patients with fever of unknown origin despite initial normal CXR.
Stenotrophomonas maltophilia is an important global emerging nosocomial pathogen[10, 11]. In neutropenic patients, the mortality rate of S. maltophilia pneumonia is up to 50%. Therefore, a prompt diagnosis of S. maltophilia pneumonia is essential and may improve patients' survival.
To the best of our knowledge, there is only one case report describing the CT features of S. maltophilia pneumonia. Here we will compare the reported findings in prior case to those found in our patients. The importance of thoracic CT in febrile neutropenic patients will also be discussed.
Infection is the major cause of neutropenic fever in patients receiving chemotherapy, with the pulmonary system being most commonly involved. Due to its high accessibility, low cost and low radiation dose, chest radiography (CXR) is most often the first imaging test used. Besides its role in detection of chest infection, CXR is also helpful in monitoring disease progress and treatment response[12–14]. According to Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America, CXR is indicated in febrile neutropenic patient who is receive chemotherapy and has upper respiratory symptoms and/or cough. Unfortunately, CXR might not be sufficiently sensitive or specific. It is well known that CXR can be normal even there are florid abnormalities in thoracic CT, as demonstrated in our patient 1. In most of the time, the radiographic findings are non specific and thus non-diagnostic. Compared to CXR, thoracic CT is far more sensitive in detection of pulmonary infection in immunocompromised patients[2–8]. In neutropenic febrile patients, thoracic CT can depict 20% more pneumonia and demonstrate pneumonia about 5 days earlier than CXR. In other words, the diagnosis and treatment of pulmonary infection in a patient with normal CXR can be delayed till abnormalities are shown in thoracic CT. Since the prognosis of patient with neutropenic fever depends on prompt identification of causative pathogen and commencement of appropriate treatment[16, 17] the role of thoracic CT in improving the prognosis of neutropenic febrile patient with pulmonary infection cannot be overstressed.
Besides being sensitive, thoracic CT is efficacious in excluding pulmonary infection. Micro-organisms are detected much more often in patients with CT features of chest infection than those with normal CT (43% versus 4%) which means that a normal thoracic CT can essentially exclude pulmonary infection. In a patient with negative septic workup and persistent fever after commencement of empirical antibiotics, the cause of persistent fever can either be due to inappropriate antimicrobial regime or non-infective cause of fever, such as malignancy related fever, reaction to incompatible blood product, metabolic disorders (e.g. gout) etc. Switching antibiotic regime without direction might not be always helpful and might even cause adverse effect. Repeating full set of septic workup or carrying out invasive tests without focus may be impractical and even harmful. Thoracic CT would then be valuable at that juncture. In patient with abnormal thoracic CT, it is sensible for us to carry out detailed workup focusing on the pulmonary system. This may include some more invasive investigation with higher diagnostic yield like bronchoalveolar lavage, transbronchial biopsy of consolidative area or lymph node. In addition, some pathogens have specific CT features that allow us to reach the correct diagnosis and start appropriate treatment before positive microbiology results, for example, air crescent sign in aspergilloma, symmetrical perihilar infiltrates in Pneumocystis jiroveci pneumonia, and central necrotic lymph nodes in pulmonary tuberculosis. Since a normal thoracic CT can essentially exclude pulmonary infection, we should then put our focus on extrapulmonary causes of fever rather than launching invasive investigation on the pulmonary system. Therefore some authors advocate the use of thoracic CT in neutropenic patients with fever of unknown origin despite initial normal CXR.
In neutropenic febrile patients with pulmonary infiltrates, infection accounts for approximately 75% of cases. Although some pathogens have specific CT features that allow us to make the correct diagnosis, most of them do not and the final diagnosis of the offending organism still relies on the microbiology results.
Stenotrophomonas (Xanthomonas) maltophilia is an aerobic, gram-negative bacillus with multi-drug resistance which is closely related to the Pseudomonas species. Being an opportunistic pathogen in immunocompromised patients, it is emerging globally in recent years. It can cause serious infections in various parts of the body, with the respiratory tract (33%) and central catheter (31%) being most commonly involved[10, 11]. There is a significantly higher risk of developing S. maltophilia disseminated infection in patients having advanced immunodeficiency, neutropenia, central venous catheterization, prior broad-spectrum antimicrobial therapy and/or corticosteroid treatment, intubation or tracheotomy, prolonged hospitalization and severe mucous lesions[10, 18]. Concerning our patients, both of them had the risk factors of being immunocompromised and neutropenic due to intrinsic malignancy and chemotherapy treatment. The overall mortality rate of neutropenic patient with S. maltophilia pneumonia is up to 50%, which is further increased to >80% in those requiring endobronchial intubation. Therefore a prompt diagnosis is essential in treatment planning and may improve patient’s morbidity and mortality.
Apart from infection, there are other differential diagnoses for pulmonary infiltrates in patients with neutropenic fever. These include radiation pneumonitis, drug toxicity and diffuse alveolar hemorrhage. All of them can show similar radiological findings as those in pneumonia. Radiation pneumonitis should be considered if there is a history of radiation therapy to the chest. In general it develops within 4–12 weeks after completion of radiation therapy in patients receiving more than 40 Gy of radiation. In the acute phase it presents as ground-glass opacities or consolidation. In the late phase traction bronchiectasis, volume loss, and consolidation can be found. Consolidation with geographic straight border that confines within the radiation port is characteristic. In pulmonary drug toxicity, there is bilateral hetero- or homogeneous ground glass opacities, usually in the mid and lower lungs. Diffuse alveolar haemorrhage (DAH) is an uncommon complication caused by certain medications, typically anticoagulants and cytotoxic drugs likely high-dose cyclophosphamide and cytarabine. It has a high mortality rate, thus prompt diagnosis is important. Imaging features consist of bilateral scattered or diffuse areas of ground-glass opacity or consolidation. In most cases these patients present with acute respiratory distress. A drop of haematocrit level is a hint to the correct diagnosis, and the presence of progressive hemorrhagic bronchoalveolar lavage is diagnostic.
To the best of our knowledge, there is only one case report describing the CT features of S. maltophilia. In that case, multifocal areas of air-space consolidation, ground-glass attenuation areas, small centrilobular nodules and bronchial wall thickening were present. In our series, the sole CT finding of patient 1 is bilateral patchy ground glass opacities without zonal predominance. Air-space consolidation, ground glass opacities, numerous centrilobular nodules and bronchial wall thickening are noted in patient 2. These are similar to those described in prior case report. Compared with that reported case, the only new imaging finding in patient 2 is bilateral cylindrical bronchiectasis. Among all three cases, diffuse ground glass opacities without zonal predominance is the most consistent CT features of S. maltophilia pneumonia. Other imaging findings such as bilateral multifocal areas of air-space consolidation and centrilobular nodules can be occasionally found. Bronchiectasis likely represents the later stage of pneumonia. However, since these imaging features and pattern are not specific nor diagnostic, the final diagnosis of S. maltophilia pneumonia still relies on microbiology results.
Stenotrophomonas maltophilia is a rare yet important globally emerging opportunistic pathogen. The most consistent CT features of S. maltophilia pneumonia is diffuse ground glass opacities without zonal predominance. Bilateral multifocal areas of air-space consolidation, centrilobular nodules, bronchiectasis and bronchial wall thickening are occasionally found. Due to its supreme sensitivity, the role of thoracic CT in the detection and exclusion of pulmonary infection, including S. maltophilia pneumonia, in neutropenic febrile patients cannot be overstressed.
Written informed consent was obtained from the patient for publication of this report and any accompanying images.
- Bodey GP: Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis. 1993, 17 (suppl 2): s378-s384.View ArticlePubMedGoogle Scholar
- Kuhlman JE, Fishman EK, Siegelman SS: Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985, 157: 611-614.View ArticlePubMedGoogle Scholar
- Mori M, Galvin JR, Barloon TJ, Gingrich RD, Stanford W: Fungal pulmonary infections after bone marrow transplantation: evaluation with radiograph and CT. Radiology. 1991, 178: 721-726.View ArticlePubMedGoogle Scholar
- Bergin CJ, Wirth RL, Berry GJ, Castellino RA: Pneumocystis carinii pneumonia: CT and HRCT observations. J Comput Assist Tomogr. 1990, 14: 756-759. 10.1097/00004728-199009000-00014.View ArticlePubMedGoogle Scholar
- Kuhlman JE, Fishman EK, Hruban RH, Knowles M, Zerhouni EA, Siegelman SS: Diseases of the chest in AIDS: CT diagnosis. Radiographics. 1989, 9: 827-857.View ArticlePubMedGoogle Scholar
- Kang EY, Patz EF, Müller NL: Cytomegalovirus pneumonia in transplant patients: CT findings. J Comput Assist Tomogr. 1996, 20: 295-299. 10.1097/00004728-199603000-00024.View ArticlePubMedGoogle Scholar
- McLoud TC, Naidich DP: Thoracic disease in the immunocompromised patient. Radio lClin North Am. 1992, 30: 525-554.Google Scholar
- Worthy S, Kang EY, Müller NL: Acute lung disease in the immunocompromised host: differential diagnosis at high-resolution CT. Semin Ultrasound CT MR. 1995, 16: 353-360. 10.1016/0887-2171(95)90024-1.View ArticlePubMedGoogle Scholar
- Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M: Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. Am J Roentgenol. 1997, 169: 1347-1353. 10.2214/ajr.169.5.9353456.View ArticleGoogle Scholar
- Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY: Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004, 37: 350-358.PubMedGoogle Scholar
- Brooke JS: Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012, 25: 2-41. 10.1128/CMR.00019-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Rosenow EC: Diffuse pulmonary infiltrates in the immunocompromised host. Clin Chest Med. 1990, 11: 55-64.PubMedGoogle Scholar
- White DA: Pulmonary infection in the immunocompromised patient. Thorac Cardiovasc Surg. 1995, 7: 78-87.Google Scholar
- Dichter JR, Levine SJ, Shelhamer JH: Approach to the immunocompromised host with pulmonary symptoms. Hematol Oncol Clin North Am. 1993, 7: 887-912.PubMedGoogle Scholar
- Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011, 2011 (52): 427-431.View ArticleGoogle Scholar
- Uhrmeister P, Astinet F, Langer M, Zwicker C, Schonfeld N, Felix RHR, Felix R: HR-CT in interstitial lung disease. Fortschr Rontgenstr. 1992, l56: 53-60.View ArticleGoogle Scholar
- Aisner J, Schimpif SC, Wiemek PH: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med. 1983, 99: 539-543. 10.7326/0003-4819-99-4-539.View ArticleGoogle Scholar
- Calza L, Manfredi R, Chiodo F: Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection. 2003, 31: 155-161.PubMedGoogle Scholar
- Ewig S, Glasmacher A, Ulrich B, Wilhelm K, Schäfer H, Nachtsheim KH: Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest. 1998, 114: 444-451. 10.1378/chest.114.2.444.View ArticlePubMedGoogle Scholar
- Choi YW, Munden RF, Erasmus JJ, Park KJ, Chung WK, Jeon SC, Park CK: Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics. 2004, 24: 985-998. 10.1148/rg.244035160.View ArticlePubMedGoogle Scholar
- Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC: Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000, 20: 1245-1259.View ArticlePubMedGoogle Scholar
- Worthy SA, Flint JD, Müller NL: Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings. Radiographics. 1997, 17: 1359-1371.View ArticlePubMedGoogle Scholar
- Gasparetto EL, Bertholdo DB, Davaus T, Marchiori E, Escuissato DL: Stenotrophomonas maltophilia pneumonia after bone marrow transplantation: case report with emphasis on the high resolution CT findings. Br J Radiol. 2007, 80: e19-e20.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.